Medical applications of accelerators

Reviews of Accelerator Science and Technology

Volumn , Issue , 2008, Pages 143-161

  Eickhoff, Hartmut ^a   Linz, Ute ^b  

^a GSI HELMHOLTZZENTRUM FÜR SCHWERIONENFORSCHUNG GMBH   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Gantry; Ion therapy; Medical accelerators

Indexed keywords

DIAGNOSIS; DIAGNOSTIC RADIOGRAPHY; DISEASES; MEDICAL APPLICATIONS; PATIENT TREATMENT;

BIOPHYSICAL PROPERTIES; CANCER PATIENTS; GANTRY; ION THERAPY; MEDICAL ACCELERATOR; MEDICAL ASPECTS; TECHNICAL SYSTEMS;

X RAY RADIOGRAPHY;

EID: 84973431559     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812835215_0007     Document Type: Chapter

References (59)

1. R. E. Zirkle, The radiobiological importance of linear energy transfer, in Radiation Biology, ed. A. Hollaender (McGraw-Hill, New York, 1954), Vol 1, pp. 315-350
2. J. Kempe et al., Med. Phys. 34, 183 (2007).
3. R. R. Wilson, Radiobiology 47, 487 (1946).
4. J. D. Slater, Technol. Cancer Res. Treat. 5, 81(2006).
5. D. Schulz-Ertner et al., J. Clin. Oncol. 25, 953 (2007).
6. G. Kraft, Prog. Part. Nucl. Phys. 45, 556 (2000).
7. U. Amaldi et al., J. Radiat Res. 48 (Suppl.), 92(2007).
8. R. Mayer et al., Radiother Oncol. 73, 107 (2004).
9. U. Amaldi, Radiother Oncol. 73, 274 (2004).
10. G. Gademann, Socio-economic aspects of hadron-therapy, Proc. 1st Int. Sympo. Hadrontherapy (Como, Italy; Octo. 18-21, 1993), p. 59.
11. J. H. Lawrence, Cancer 10, 795 (1957).
12. M. Jermann, Hadron therapy patient statistics, http://ptcog.web.psi.ch/Archive/Patient_data_Dec-07.pdf (Mar. 2008).
13. K. Sato et al., Nucl. Phys. A 588, 229 (1995).
14. A. Itano, Natl. Inst. Radiol. Sci. M 156, 6 (2002).
15. A. Itano, PIMMS Parts I and II, CERN/PS 1999-010 DI and CERN/PS 2000-007 DR, (Genova).
16. H. Eickhoff, HICAT: The German Hospital-Based Light Ion Cancer Therapy Project (EPAC 2004, Lucerne).
17. S. Rossi, Developments in proton and light-ion therapy (EPAC 2006, Edinburgh).
18. H. Blattmann et al., NUPECC (Dec. 27-41, 1994).
19. R. Maughan et al., Status Report for the Harper Hospital Superconducting Cyclotron Neutron Therapy Facility, CP600, Proc. Cyclotrons and Applications 18 (2001).
20. F. J. Prott et al., Bull. Cancer. Radiother. 83, 115 (1996).
21. U. Linz, Technol Cancer Res. Treat. 7, 83 (2008).
22. P. H. Fowler et al., Nature 189, 524 (1961).
23. H. Blattmann, New developments at PSI, in Ion Beams in Tumor Therapy, ed. U. Linz (Chapman and Hall, Weinheim, 1995), pp. 333-340.
24. G. Schmitt et al., Radiat. Res. Suppl. 8, S272 (1985).
25. S. M. Qaim, Radiochim. Acta 89, 223 (2001).
26. E. B. Hughes et al., Nucl. Instrum. Methods. Phys. Res. A 246, 719 (1986).
27. E. Pedroni et al., Z. Med. Phys. 14, 25 (2004).
28. J. B. Flanz, Nucl. Instrum. Methods. Phys. Res. B 261, 768 (2007).
29. U. Weinrich, Gantry design for proton and hadron-therapy facilities, in EPAC 2006 (Edinburgh).
30. D. Trbojevic et al., A dramatically reduced size in the gantry design for the proton-carbon therapy, in EPAC 2006 (Edinburgh).
31. T. Furukawa et al., Design study of scanning system and rotating gantry for HIMAC new treatment facility, in Proc. NIRS-CNAO Joint Symp. Carbon Ion Radiotherapy (2006), pp. 142-153.
32. C. Johnstone et al. in New nonscaling FFAG for medical applications, in PAC 2007.
33. W. Enghardt, Phys. Med. Biol. 37, 2127 (1992).
34. W. Enghardt et al., Nucl. Instrum. Methods. Phys. Res. A 525, 284 (2004).
35. M. Kramer et al., Phys. Med. Biol. 45, 3299 (2000).
36. W. Enghardt et al., Radiother. Oncol. 73, S96 (2004).
37. M. Kanazawa et al., Present status of HIMAC at NIRS, in Proc. 1999 Particle Accelerator Conference (New York, 1999), pp. 599-602.
38. M. Kanazawa et al., Nucl. Phys. A 701, 244 (2002).
39. T. Misu et al., Phys. Rev. ST - Accel. Beams 7, 094701, 2004(E-Publ).
40. U. Amaldi et al., Nucl. Instrum. Methods Phys. Res. A 521, 512 (2004).
41. Y.-J. Chen et al., Compact proton accelerators for cancer therapy, TUPAS059, in PAC 2007 (Albuquerque).
42. M. Maggiore et al., Design studies of the 300 AMeV Superconducting Cyclotron for Hadrontherapy, in PAC 2007 (Albuquerque).
43. A. Noda et al., Ion production with a high-power short-pulse laser for application to cancer therapy, in EPAC 2002 (Paris), pp. 2748-2750.
44. V. Malka et al., Med. Phys. 31, 1587 (2004).
45. M. Borghesi et al., J. Phys. Conf. Ser. 58, 74 (2007).
46. U. Linz et al., Phys. Rev. ST-Accel. Beams. 10, 2007 (E-Publ.).
47. M. H. Holzscheiter et al., Radiother. Oncol. 81, 233 (2006).
48. S. Grotzinger et al., Phys. Med. Biol. 51, 3517 (2006).
49. R. Lin et al., Int. J. Radiat. Oncol. Biol. Phys. 48, 1219 (2000).
50. R. Miralbell et al., Int. J. Rad. Oncol. Biol, Phys. 54, 824 (2002).
51. E. Hall et al., Int. J. Radiat. Oncol. Biol. Phys. 56, 83 (2003).
52. U. Schneider et al., Phys. Med. 17, S97 (2001).
53. E. B. Hug, Radiother. Oncol. 73, S35 (2004).
54. N. Matsufuji et al., Phys. Med. Biol. 48, 1605 (2003).
55. S. Koike et al., Radiat. Prot. Dos. 99, 405 (2002).
56. K. Ando et al., J. Radiat. Res. 46, 51 (2005).
57. H. Tsujii et al., J. Radiat. Res. 48 (Suppl), 46(2007).
58. M. Goitein et al., Clin. Oncol. 15, S37 (2003).
59. J. Lundkvist et al., Acta. Oncol. 44, 850 (2005).